{"disease":{"id":"alzheimers-disease-prevention","name":"alzheimers disease prevention"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06831812","title":"Phase I Clinical Study of AV-1959R: Abeta-targeting Anti-Alzheimer's Vaccine","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Nuravax, Inc.","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}